首页> 外文期刊>BMC Anesthesiology >Association of intraoperative hyperglycemia and postoperative outcomes in patients undergoing non-cardiac surgery: a multicenter retrospective study
【24h】

Association of intraoperative hyperglycemia and postoperative outcomes in patients undergoing non-cardiac surgery: a multicenter retrospective study

机译:非心脏手术患者术中高血糖和术后结果的关联:多中心回顾性研究

获取原文
           

摘要

While pre and postoperative hyperglycemia is associated with increased risk of surgical site infection, myocardial infarction, stroke and risk of death, there are no multicenter data regarding the association of intraoperative blood glucose levels and outcomes for the non-cardiac surgical population. We conducted a retrospective cohort study from the Michigan Surgical Quality Collaborative, a network of 64 hospitals that prospectively collects validated data on surgical patients for the purpose of quality improvement. We included data for adult general, vascular, endocrine, hepatobiliary, and gastrointestinal operations between 2013 and 2015. We assessed the risk-adjusted, independent relationship between intraoperative hyperglycemia (glucose ?180) and the primary outcome of 30-day morbidity/mortality and secondary outcome of infectious complications using multivariable logistic regression modelling. Post hoc sensitivity analysis to assess the association between blood glucose values ≥250?mg/dL and outcomes was also performed. Ninety-two thousand seven hundred fifty-one patients underwent surgery between 2013 and 2015 and 5014 (5.4%) had glucose testing intra-operatively. Of these patients, 1647 patients (32.9%) experienced the primary outcome, and 909 (18.1%) the secondary outcome. After controlling for patient comorbidities and surgical factors, peak intraoperative glucose ?180?mg/dL was not an independent predictor of 30-day mortality/morbidity (adjusted OR 1.05, 95%CI:0.86 to 1.28; p-value 0.623; model c-statistic of 0.720) or 30-day infectious complications (adjusted OR 0.93, 95%CI:0.74,1.16; p 0.502; model c-statistic of 0.709). Subgroup analysis for patients with or without diabetes yielded similar results. Sensitivity analysis demonstrated blood glucose of 250?mg/dL was a predictor of 30-day mortality/morbidity (adjusted OR: 1.59, 95% CI: 1.24, 2.05; p 180?mg/ dL compared to patients with glucose values ≤180?mg/ dL.
机译:虽然先前和术后高血糖与手术部位感染的风险增加,心肌梗塞,中风和死亡风险,但没有关于非心脏手术人群的术中血糖水平和结果的关联的多中心数据。我们从密歇根外科课程中进行了回顾性的队列研究,这是一个64家医院网络,前瞻性地收集手术患者的验证数据,以便质量改进。我们包括2013年和2015年之间成人一般,血管,内分泌,肝胆碱和胃肠道的数据。我们评估了术中高血糖(葡萄糖> 180)之间的风险调整,独立关系,以及30天发病率/死亡率的主要结果多变量逻辑回归建模的传染性并发​​症的次要结果。后HOC敏感性分析评估血糖值之间的关联≥250?MG / DL和结果。九十二千七百五十一患者在2013年和2015年之间进行手术,5014(5.4%)在可操作地具有葡萄糖测试。在这些患者中,1647名患者(32.9%)经历了主要结果,909(18.1%)的次要结果。在控制患者的患者和外科因素后,山峰术中葡萄糖> 180?Mg / DL不是30天死亡率/发病率的独立预测因子(调节或1.05,95%CI:0.86至1.28; p值0.623;模型C-统计为0.720)或30天的传染性并发​​症(调节或0.93,95%CI:0.74,1.16; P 0.502;模型C统计为0.709)。患有或没有糖尿病患者的亚组分析产生类似的结果。敏感性分析显示250〜mg / dl的血糖是30天死亡率/发病率的预测因子(调节或:1.59,95%Ci:1.24,2.05; p 180?mg / dl与葡萄糖值≤180相比≤180 mg / dl。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号